Is Bombay Super Hyb overvalued or undervalued?

As of 15 September 2025, the valuation grade for Bombay Super Hyb has moved from very expensive to expensive, indicating a slight improvement in its valuation outlook. Despite this change, the company remains overvalued based on its current metrics. The PE ratio stands at 51.52, the Price to Book Value is 13.57, and the EV to EBITDA ratio is 43.83, all of which are significantly higher than industry averages.
In comparison to its peers, Jain Irrigation has a PE ratio of 119.93 and an EV to EBITDA of 10.76, while Indo US Bio-Tech shows a PE of 16.23 and an EV to EBITDA of 14.65, highlighting that Bombay Super Hyb's valuations are not justified when looking at these benchmarks. Additionally, the company's recent stock performance has been underwhelming, with a year-to-date return of -12.68%, contrasting sharply with the Sensex's gain of 6.02% in the same period. Overall, the analysis suggests that Bombay Super Hyb is overvalued in the current market environment.